![Daniel J. Meichelbock](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Daniel J. Meichelbock
Portfolio Manager-Aktien bei MH & Associates Securities Management Corp.
Aktive Positionen von Daniel J. Meichelbock
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MH & Associates Securities Management Corp.
![]() MH & Associates Securities Management Corp. Investment ManagersFinance MH & Associates Securities Management Corp. (MH & Associates) is an independent, SEC-registered investment advisor headquartered in Carlsbad, California. The firm was founded by J. Robert Meichelbock and John Heilman in 1981. MH & Associates provides investment management services to families, companies and institutions. | Portfolio Manager-Aktien | 01.01.2000 | - |
Karriereverlauf von Daniel J. Meichelbock
Ehemalige bekannte Positionen von Daniel J. Meichelbock
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bradley Pharmaceuticals, Inc.
![]() Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | Corporate Officer/Principal | 01.01.1997 | - |
Ausbildung von Daniel J. Meichelbock
University of California, Los Angeles | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Portfolio Manager-Equities | 1 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Finance | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
MH & Associates Securities Management Corp.
![]() MH & Associates Securities Management Corp. Investment ManagersFinance MH & Associates Securities Management Corp. (MH & Associates) is an independent, SEC-registered investment advisor headquartered in Carlsbad, California. The firm was founded by J. Robert Meichelbock and John Heilman in 1981. MH & Associates provides investment management services to families, companies and institutions. | Finance |
Bradley Pharmaceuticals, Inc.
![]() Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | Health Technology |
- Börse
- Insiders
- Daniel J. Meichelbock
- Erfahrung